If you were a Dividend.com Premium member, you would be seeing detailed dividend stock ratings information for Teva Pharmaceuticals (TEVA) in this space. Sign up for Dividend.com Premium today to gain access to ratings on over 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!
Teva Pharmaceuticals- (TEVA)-is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.
* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.
** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
The following dividend stocks are considered direct competitors of Teva Pharmaceuticals (TEVA):
RELATED COMPANIES
The following dividend stocks are in the same sector as Teva Pharmaceuticals (TEVA):
Add TEVA to My Watchlist »
View Historical Dividend Data for TEVA »
View a Sample of Our Stock Ratings
Company Profile
OFFERS FROM OUR SPONSORS
DIRECT COMPETITORS
RELATED COMPANIES
MORE RESEARCH
RSS Feeds